Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
Boston Scientific Corporation
Varian, a Siemens Healthineers Company
Linnaeus Therapeutics, Inc.
Brooklyn ImmunoTherapeutics, LLC
Lumos Pharma
Lumos Pharma
Immunicom Inc
Aduro Biotech, Inc.
DNAtrix, Inc.
Cell Genesys